PRNP and prion disease: Both cell culture and animal experiments have supported the use of anti-PrP monoclonal antibodies to inhibit the incorporation of PrPC into propagating prions and delay the progression of prion disease (Enari et al., 2001; Peretz et al., 2001; White et al., 2003; Song et al., 2008).